Local production has emerged as an essential part of the solution for ensuring sustainable and equitable supplies of vaccines in low- and middle-income countries. This webinar will explore how might local manufacturing and the new mRNA Hub in South Africa facilitate access and support R&D.
Featuring Petro Terblanche of Afrigen Biologics, Ike James of Medicines Patent Pool, and Mike Frick of Treatment Action Group.
Recording / Caryn Fenner Slides / Mike Frick Slides / Ike James Slides